S&P Equity Research Initiates Coverage on Theravance (THRX) with a Buy
Tweet Send to a Friend
S&P Equity Research initiates coverage on Theravance (Nasdaq: THRX) with a Buy.
S&P analyst, S. Sliver, says, "THRX develops ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
S&P analyst, S. Sliver, says, "THRX develops ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
